RAPSN
43 kDa receptor-associated protein of the synapse
Also known as: CMS1D, CMS1E, RAPSN_HUMAN, RNF205
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13702
- Gene
- RAPSN
- Ensembl
- ENSG00000165917
- Chromosome
- 11
- Canonical length
- 412 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Centrosome,Cytosol
OverviewNCBI Gene
This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
Canonical amino-acid sequenceUniProt
412 residues, UniProt reviewed canonical sequence.
>Q13702|RAPSN
1 MGQDQTKQQI EKGLQLYQSN QTEKALQVWT KVLEKSSDLM GRFRVLGCLV TAHSEMGRYK
61 EMLKFAVVQI DTARELEDAD FLLESYLNLA RSNEKLCEFH KTISYCKTCL GLPGTRAGAQ
121 LGGQVSLSMG NAFLGLSVFQ KALESFEKAL RYAHNNDDAM LECRVCCSLG SFYAQVKDYE
181 KALFFPCKAA ELVNNYGKGW SLKYRAMSQY HMAVAYRLLG RLGSAMECCE ESMKIALQHG
241 DRPLQALCLL CFADIHRSRG DLETAFPRYD SAMSIMTEIG NRLGQVQALL GVAKCWVARK
301 ALDKALDAIE RAQDLAEEVG NKLSQLKLHC LSESIYRSKG LQRELRAHVV RFHECVEETE
361 LYCGLCGESI GEKNSRLQAL PCSHIFHLRC LQNNGTRSCP NCRRSSMKPG FVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAPSN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 83 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 83 nTPM
- tongue: 31 nTPM
- heart muscle: 2.5 nTPM
- placenta: 2 nTPM
- adrenal gland: 1.4 nTPM
- salivary gland: 1.3 nTPM
Single-cell type
- myosatellite cells: 67 nCPM
- myonuclei: 45 nCPM
- late spermatids: 22 nCPM
- thymic myoid cells: 16 nCPM
- neutrophils: 8.7 nCPM
- epididymal efferent duct absorptive cells: 7.7 nCPM
Immune cell
- neutrophil: 0.4 nTPM
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 2.4 nTPM
- choroid plexus: 1.7 nTPM
- thalamus: 1.2 nTPM
- amygdala: 1.1 nTPM
- hippocampal formation: 1 nTPM
- white matter: 1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RAPSN.
Disease | AllUniProt
Conditions RAPSN is implicated in, by any mechanism.
- Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (CMS11) MIM:616326
- Fetal akinesia deformation sequence 2 (FADS2) MIM:618388
Disease | GeneticClinVar
114 pathogenic / likely-pathogenic of 754 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital myasthenic syndrome 11
- Fetal akinesia deformation sequence 1
- Fetal akinesia deformation sequence 2
- Congenital myasthenic syndrome
- RAPSN-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.55
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemical synaptic transmission
- motor neuron apoptotic process
- neurotransmitter receptor localization to postsynaptic specialization membrane
- positive regulation of motor neuron apoptotic process
- positive regulation of neuromuscular synaptic transmission
- skeletal muscle acetylcholine-gated channel clustering
- synaptic transmission, cholinergic
- establishment of protein localization to postsynaptic membrane
- regulation of postsynaptic membrane organization
Molecular functions
- acetylcholine receptor binding
- ionotropic glutamate receptor binding
- protein-membrane adaptor activity
- structural constituent of postsynaptic specialization
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RING-type
- Tetratricopeptide-like helical domain superfamily
- Zinc finger, RING/FYVE/PHD-type
- Tetratricopeptide repeat
- Tetratricopeptide repeat
- Ring finger domain
- 43kDa postsynaptic protein
- 43kDa postsynaptic, conserved site
- Rapsyn, myristoylation/linker region, N-terminal
- Receptor-associated synaptic protein
- Rapsyn N-terminal myristoylation and linker region
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RAPSN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAPSN as an antibody target. Whether an autoantibody or antibody against RAPSN could matter depends on whether native RAPSN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAPSN is annotated at the cell surface, where native RAPSN is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RAPSN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...